Overview

Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control, weight change and hypoglycaemic effects in patients with type 2 diabetes with Levemir® compared to Insulatard® under normal clinical practice conditions.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human